221 related articles for article (PubMed ID: 15751739)
1. Recent advances in antileishmanial drug development.
Davis AJ; Kedzierski L
Curr Opin Investig Drugs; 2005 Feb; 6(2):163-9. PubMed ID: 15751739
[TBL] [Abstract][Full Text] [Related]
2. Current approaches to discover marine antileishmanial natural products.
Tempone AG; Martins de Oliveira C; Berlinck RG
Planta Med; 2011 Apr; 77(6):572-85. PubMed ID: 21243582
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial peptides for leishmaniasis.
Cobb SL; Denny PW
Curr Opin Investig Drugs; 2010 Aug; 11(8):868-75. PubMed ID: 20721829
[TBL] [Abstract][Full Text] [Related]
4. Leishmania vaccines: progress and problems.
Kedzierski L; Zhu Y; Handman E
Parasitology; 2006; 133 Suppl():S87-112. PubMed ID: 17274851
[TBL] [Abstract][Full Text] [Related]
5. Rational approaches for drug designing against leishmaniasis.
Shukla AK; Singh BK; Patra S; Dubey VK
Appl Biochem Biotechnol; 2010 Apr; 160(8):2208-18. PubMed ID: 19756413
[TBL] [Abstract][Full Text] [Related]
6. A review of natural products with antileishmanial activity.
Rocha LG; Almeida JR; Macêdo RO; Barbosa-Filho JM
Phytomedicine; 2005 Jun; 12(6-7):514-35. PubMed ID: 16008131
[TBL] [Abstract][Full Text] [Related]
7. Modes of action of Leishmanicidal antimicrobial peptides.
Marr AK; McGwire BS; McMaster WR
Future Microbiol; 2012 Sep; 7(9):1047-59. PubMed ID: 22953706
[TBL] [Abstract][Full Text] [Related]
8. Alkaloids: future prospective to combat leishmaniasis.
Mishra BB; Kale RR; Singh RK; Tiwari VK
Fitoterapia; 2009 Mar; 80(2):81-90. PubMed ID: 19015012
[TBL] [Abstract][Full Text] [Related]
9. Leishmaniasis: drug resistance and natural products (review).
Polonio T; Efferth T
Int J Mol Med; 2008 Sep; 22(3):277-86. PubMed ID: 18698485
[TBL] [Abstract][Full Text] [Related]
10. Isolation of antileishmanial sterol from the fruits of Cassia fistula using bioguided fractionation.
Sartorelli P; Andrade SP; Melhem MS; Prado FO; Tempone AG
Phytother Res; 2007 Jul; 21(7):644-7. PubMed ID: 17397117
[TBL] [Abstract][Full Text] [Related]
11. Leishmanicidal constituents from the leaves of Piper rusbyi.
Flores N; Cabrera G; Jiménez IA; Piñero J; Giménez A; Bourdy G; Cortés-Selva F; Bazzocchi IL
Planta Med; 2007 Mar; 73(3):206-11. PubMed ID: 17354169
[TBL] [Abstract][Full Text] [Related]
12. Leishmania spp.: proficiency of drug-resistant parasites.
Natera S; Machuca C; Padrón-Nieves M; Romero A; Díaz E; Ponte-Sucre A
Int J Antimicrob Agents; 2007 Jun; 29(6):637-42. PubMed ID: 17353113
[TBL] [Abstract][Full Text] [Related]
13. Plant derived therapeutics for the treatment of Leishmaniasis.
Sen R; Chatterjee M
Phytomedicine; 2011 Sep; 18(12):1056-69. PubMed ID: 21596544
[TBL] [Abstract][Full Text] [Related]
14. New antileishmanial candidates and lead compounds.
Richard JV; Werbovetz KA
Curr Opin Chem Biol; 2010 Aug; 14(4):447-55. PubMed ID: 20400358
[TBL] [Abstract][Full Text] [Related]
15. A novel isoflavonoid from Millettia puguensis.
Kapingu MC; Mbwambo ZH; Moshi MJ; Magadula JJ; Cos P; Berghe DV; Maes L; Theunis M; Apers S; Pieters L; Vlietinck A
Planta Med; 2006 Nov; 72(14):1341-3. PubMed ID: 17054049
[TBL] [Abstract][Full Text] [Related]
16. Kahalalide F, an antitumor depsipeptide in clinical trials, and its analogues as effective antileishmanial agents.
Cruz LJ; Luque-Ortega JR; Rivas L; Albericio F
Mol Pharm; 2009; 6(3):813-24. PubMed ID: 19317431
[TBL] [Abstract][Full Text] [Related]
17. Limitations of Current Therapeutic Options, Possible Drug Targets and Scope of Natural Products in Control of Leishmaniasis.
Tiwari N; Gedda MR; Tiwari VK; Singh SP; Singh RK
Mini Rev Med Chem; 2018; 18(1):26-41. PubMed ID: 28443518
[TBL] [Abstract][Full Text] [Related]
18. Peptides to Tackle Leishmaniasis: Current Status and Future Directions.
Robles-Loaiza AA; Pinos-Tamayo EA; Mendes B; Teixeira C; Alves C; Gomes P; Almeida JR
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922379
[TBL] [Abstract][Full Text] [Related]
19. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
20. Complementary medicinal chemistry-driven strategies toward new antitrypanosomal and antileishmanial lead drug candidates.
Cavalli A; Lizzi F; Bongarzone S; Belluti F; Piazzi L; Bolognesi ML
FEMS Immunol Med Microbiol; 2010 Feb; 58(1):51-60. PubMed ID: 19845762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
